HypertensionPocPep-CVDNCT02585089
Effects of Cured Pork Peptides on Blood Pressure & Cardiovascular Risk Factors
A study testing Spanish cured-pork ham and Cooked pork ham in people with Hypertension and Cardiovascular Diseases, run by Universidad Católica San Antonio de Murcia at 1 site in Spain.
Trial summary
Spanish dry-cured ham has been shown a source of antihypertensive peptides in mice. To date, no clinical study has been performed in humans to check the effects of bioactive peptides produced naturally during the processing of pork dry-cured ham on blood pressure. Read more about this study
- Who is it for?
- Ages 35 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Hypertension, Cardiovascular Diseases
- What is being tested?
- Spanish cured-pork ham and Cooked pork ham
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 50 participants
- Where
- 1 siteSpain
- Study dates
- Oct 2015to Sep 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Caucasian men and women,
- aged 35-60 years in good general health with an average of systolic arterial pressure >130 mmHg and diastolic >80 mmHg.
Who cannot join
- smokers,
- Diabetes mellitus,
- diagnosed and treated hypertension,
- history of cardiovascular events (stroke, myocardial infarction or peripheral vascular disease),
- receiving medications: anti-hypertensives, vasodilators, lipid lowering therapies and fish oil supplements unless willing to discontinue prior to \& during study (all other supplements will be assessed on a case by case basis).
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Beneficial Effects of Pork Bioactive Peptides on Cardiovascular Health in Humans
Spanish dry-cured ham has been shown a source of antihypertensive peptides in mice. To date, no clinical study has been performed in humans to check the effects of bioactive peptides produced naturally during the processing of pork dry-cured ham on blood pressure. Therefore, the aim of the present study is to investigate whether consuming peptides from cured pork ham with demonstrated angiotensin I-converting enzyme (ACE) inhibitory activity lowers blood pressure (BP) and improves other risk factors for cardiovascular disease (CVD).
Objectives: To demonstrate the lowering effects of bioactive peptides from cured pork ham with >10 months dry-curing process in humans. To check for other possible benefits related to dry-cured ham intake such as: platelet activation and cardiovascular risk factors.
Read the detailed description
A two-arm cross-over clinical study with a diet control will be assessed at the Catholic University of Murcia (UCAM).
A recruitment of 50 volunteers will be attempted in order to fulfil the UCC calculations. The 50 patients will be divided into two groups (25 vs 25). One group will receive dry-cured pork ham of >10 months proteolysis (intervention product) while the other will receive cooked, uncured ham (control product), each for one month. After two weeks wash out, the groups will be exchanged for one additional month. In this way, each group will take cooked ham and dry-cured pork ham for 28 days each arm.
Pork hams Two pork hams from the same raw meat will be used in the present study: dry-cured pork ham with >10 months dry-curing process as the intervention product and cooked, uncured ham as the control product. Both products will be purchased in vacuum bags and labelled with safety information (expiration date, nutritional composition and storage information).
Dry-cured ham with reduced salt will be used in order to decrease the sodium intake that could affect BP too. Such ham contains 25% lower salt than similar products on the market (3,7g vs 4,5g/100g) (see leaflet of a possible ham enclosed).
Dry-cured ham (80g) will be taken daily by the volunteers (50% humidity); BP will be measured as follows. In order to counteract the higher water contain (70% humidity), a higher amount of cooked ham will be given to the control groups (100g). Besides, cooked ham contains 2.5g salt/100g which is in relation with the 2,96g salt/80g reduced salt dry-cured ham. A restriction list food will be also given to the volunteers in order to control salt intake.
Volunteers Caucasian men and women, aged 35-60 years, in good general health with an average of systolic arterial pressure >130 mmHg and diastolic > 80 mmHg will be recruited. Exclusion criteria are: smokers, Diabetes mellitus, diagnosed and treated hypertension, history of cardiovascular events (stroke, myocardial infarction or peripheral vascular disease), medications: anti-hypertensives, vasodilators, lipid lowering therapies and fish oil supplements unless willing to discontinue prior to and during study (all other supplements will be assessed on a case by case basis).
Weight, height, body mass index and waist circumference will be measured at the beginning of the study by qualified nurses. A list of restricted food will be given at the beginning of the study in order to avoid excessive salt consumption.
Besides, three 24h intake surveys will be conducted for three no consecutive days (one of them on Sunday) during the study. Another survey regarding their diet habits and salt intake will be also conducted three times, once with each ham and in wash out period.
Blood pressure measurements Blood pressure will be measured with two different approaches: 24h ambulatory monitoring of BP.
24h ambulatory monitoring. A 24h recording will be assessed to all the volunteers included in the study at four different time points (before/after control product and before/after intervention product). Volunteers will be appointed for a blood extraction and a digital manometer device OMRON M24/7 BP5 properly calibrated will be installed to each volunteer.
Home auto-monitoring of BP. Auto-measurement of BP will be performed following the recommendations of the Spanish Society of Hypertension, Spanish League Against Hypertension (SEHLELHA) and the European Society of Hypertension (ESH) three times during each intervention. On the day of first appointment at the doctor office, individuals will be taught how to auto-measure its BP at home and the dominant arm will be determined. A digital manometer device OMROM 705CP properly calibrated will be given to each volunteer for a short period of time. BP will be measured 3 times during each interventional product (cured pork ham and cooked ham) as follows. The three different days, the volunteer will be asked to measure three times per day (before breakfast, 2h after pork consumption -preferably before lunch- and before dinner), and each measurement will be repeated for three times, about one minute apart. The volunteer will measure its BP seated after resting 5 min in this position, he will not smoke, ingest food or caffeine beverages (coffee, tea or colas), or exercise (including stair climbing) in the previous 30 minutes prior to the time of measurement. Measurements will be done in the dominant arm. The systolic and diastolic blood pressure readings will be recorded. The mean of the three measures will be used for all analyses.
Biochemical parameters Blood will be taken before each phase (cured pork ham/cooked ham) and after the end of such intakes, following by a 2 weeks wash out period (total 4 time points). Blood analysis will be performed after fasting for at least 8 hours.
Blood lipid profile (total cholesterol, HDL, LDL and triglycerides); hemogram, plasma glucose, creatinine, albumin and uric acid will be measured.
Plasma will be collected and stored at -80ºC for further analysis such as C reactive protein, fibrinogen and interleukins if the case.
Participants will be asked to provide a 24-hour urine collection and they will be given written and verbal instructions for the 24-hour collection. The first urine of the day will be discarded and all urine over the following 24 hours will be collected in standard containers that will be provided. Total volume of the collection will be measured by the volunteers. Urine collections will be rejected if 24-hour urinary volumes were less than 250 mL, or if the timing of the collection fell outside the range of 20-28 hours. In accordance with the standard procedure, urinary sodium and potassium will be measured using ion selecting electrode method.
Daily salt intake will be estimated based on calculation of 24-hour urinary sodium excretion on the assumption that all sodium ingested was in the form of sodium chloride.
- Conditions
- Hypertension, Cardiovascular Diseases
- Being tested
- Spanish cured-pork ham, Cooked pork ham
- Keywords
- Hypertension, active biopeptide, cardiovascular pathophysiology, angiotensin converting enzyme inhibition, cured-pork ham
- Medical subject headings
- Hypertension, Cardiovascular Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Spanish cured-pork hamOther
Dry-cured ham with reduced salt will be used in order to decrease the sodium intake that could affect blood pressure too. Such ham contains 25% lower salt than similar products on the market (3,7g vs 4,5g/100g).
Volunteers will receive 80g of cured pork ham daily for 28 consecutive days. They can eat the interventional product at any time of the day.
Cooked pork hamOther
Volunteers will receive 100g of cooked pork ham daily for 28 consecutive days. They can eat the product (placebo product) at any time of the day.
| Study group | Role | What they receive |
|---|---|---|
| Spanish cured-pork ham | Active comparator | One group will receive dry-cured pork ham of >10 months proteolysis (intervention product).
Intervention: Dietary intake Dry-cured pork ham contains high doses of bioactive peptides produced during more than 10 months of proteolysis. Receives: Other: Spanish cured-pork ham |
| Cooked pork ham | Placebo comparator | The other group will receive cooked, uncured ham (placebo product). Intervention: Dietary intake. Cooked ham does not display bioactive peptides as they are produced during proteolysis of pork ham. Receives: Other: Cooked pork ham |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from Baseline in Systolic Blood Pressure at 28 days
24h holters (OMROM) will be used for comparing blood pressure during the study
Measured: Before/after 28 days of interventional product and placebo product
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Oct 2015 (estimated)
- Study startOct 2015
- Primary completionApr 2016
- Study completionSep 2016 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HypertensionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Universidad Católica San Antonio de Murcia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, LUIS TEJADA PORTERO, Universidad Católica San Antonio de Murcia
- Investigators
- Pilar Zafrilla, PhD, Study chair, UCAM
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02585089
- Sponsor's protocol ID
- UCAM-BACCHUS
- Acronym
- PocPep-CVD
- Status last verified
- Jul 2016
- First submitted
- 31 Jul 2015
- Last updated
- 26 Jul 2016
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 26 Jul 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Beneficial Effects of Pork Bioactive Peptides on Cardiovascular Health in Humans
- ClinicalTrials.gov ID
- NCT02585089
- Acronym / sponsor ID
- PocPep-CVD / UCAM-BACCHUS
- Conditions
- Hypertension, Cardiovascular Diseases
- Keywords
- Hypertension, active biopeptide, cardiovascular pathophysiology, angiotensin converting enzyme inhibition, cured-pork ham
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Universidad Católica San Antonio de MurciaUniversity, hospital or other
- Study start
- Oct 2015
- Primary completion
- Apr 2016 (actual)
- Study completion
- Sep 2016 (estimated)
- First posted
- 23 Oct 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Spanish dry-cured ham has been shown a source of antihypertensive peptides in mice. To date, no clinical study has been performed in humans to check the effects of bioactive peptides produced naturally during the processing of pork dry-cured ham on blood pressure. Therefore, the aim of the present study is to investigate whether consuming peptides from cured pork ham with demonstrated angiotensin I-converting enzyme (ACE) inhibitory activity lowers blood pressure (BP) and improves other risk factors for cardiovascular disease (CVD).
Objectives: To demonstrate the lowering effects of bioactive peptides from cured pork ham with >10 months dry-curing process in humans. To check for other possible benefits related to dry-cured ham intake such as: platelet activation and cardiovascular risk factors.
Detailed description
A two-arm cross-over clinical study with a diet control will be assessed at the Catholic University of Murcia (UCAM).
A recruitment of 50 volunteers will be attempted in order to fulfil the UCC calculations. The 50 patients will be divided into two groups (25 vs 25). One group will receive dry-cured pork ham of >10 months proteolysis (intervention product) while the other will receive cooked, uncured ham (control product), each for one month. After two weeks wash out, the groups will be exchanged for one additional month. In this way, each group will take cooked ham and dry-cured pork ham for 28 days each arm.
Pork hams Two pork hams from the same raw meat will be used in the present study: dry-cured pork ham with >10 months dry-curing process as the intervention product and cooked, uncured ham as the control product. Both products will be purchased in vacuum bags and labelled with safety information (expiration date, nutritional composition and storage information).
Dry-cured ham with reduced salt will be used in order to decrease the sodium intake that could affect BP too. Such ham contains 25% lower salt than similar products on the market (3,7g vs 4,5g/100g) (see leaflet of a possible ham enclosed).
Dry-cured ham (80g) will be taken daily by the volunteers (50% humidity); BP will be measured as follows. In order to counteract the higher water contain (70% humidity), a higher amount of cooked ham will be given to the control groups (100g). Besides, cooked ham contains 2.5g salt/100g which is in relation with the 2,96g salt/80g reduced salt dry-cured ham. A restriction list food will be also given to the volunteers in order to control salt intake.
Volunteers Caucasian men and women, aged 35-60 years, in good general health with an average of systolic arterial pressure >130 mmHg and diastolic > 80 mmHg will be recruited. Exclusion criteria are: smokers, Diabetes mellitus, diagnosed and treated hypertension, history of cardiovascular events (stroke, myocardial infarction or peripheral vascular disease), medications: anti-hypertensives, vasodilators, lipid lowering therapies and fish oil supplements unless willing to discontinue prior to and during study (all other supplements will be assessed on a case by case basis).
Weight, height, body mass index and waist circumference will be measured at the beginning of the study by qualified nurses. A list of restricted food will be given at the beginning of the study in order to avoid excessive salt consumption.
Besides, three 24h intake surveys will be conducted for three no consecutive days (one of them on Sunday) during the study. Another survey regarding their diet habits and salt intake will be also conducted three times, once with each ham and in wash out period.
Blood pressure measurements Blood pressure will be measured with two different approaches: 24h ambulatory monitoring of BP.
24h ambulatory monitoring. A 24h recording will be assessed to all the volunteers included in the study at four different time points (before/after control product and before/after intervention product). Volunteers will be appointed for a blood extraction and a digital manometer device OMRON M24/7 BP5 properly calibrated will be installed to each volunteer.
Home auto-monitoring of BP. Auto-measurement of BP will be performed following the recommendations of the Spanish Society of Hypertension, Spanish League Against Hypertension (SEHLELHA) and the European Society of Hypertension (ESH) three times during each intervention. On the day of first appointment at the doctor office, individuals will be taught how to auto-measure its BP at home and the dominant arm will be determined. A digital manometer device OMROM 705CP properly calibrated will be given to each volunteer for a short period of time. BP will be measured 3 times during each interventional product (cured pork ham and cooked ham) as follows. The three different days, the volunteer will be asked to measure three times per day (before breakfast, 2h after pork consumption -preferably before lunch- and before dinner), and each measurement will be repeated for three times, about one minute apart. The volunteer will measure its BP seated after resting 5 min in this position, he will not smoke, ingest food or caffeine beverages (coffee, tea or colas), or exercise (including stair climbing) in the previous 30 minutes prior to the time of measurement. Measurements will be done in the dominant arm. The systolic and diastolic blood pressure readings will be recorded. The mean of the three measures will be used for all analyses.
Biochemical parameters Blood will be taken before each phase (cured pork ham/cooked ham) and after the end of such intakes, following by a 2 weeks wash out period (total 4 time points). Blood analysis will be performed after fasting for at least 8 hours.
Blood lipid profile (total cholesterol, HDL, LDL and triglycerides); hemogram, plasma glucose, creatinine, albumin and uric acid will be measured.
Plasma will be collected and stored at -80ºC for further analysis such as C reactive protein, fibrinogen and interleukins if the case.
Participants will be asked to provide a 24-hour urine collection and they will be given written and verbal instructions for the 24-hour collection. The first urine of the day will be discarded and all urine over the following 24 hours will be collected in standard containers that will be provided. Total volume of the collection will be measured by the volunteers. Urine collections will be rejected if 24-hour urinary volumes were less than 250 mL, or if the timing of the collection fell outside the range of 20-28 hours. In accordance with the standard procedure, urinary sodium and potassium will be measured using ion selecting electrode method.
Daily salt intake will be estimated based on calculation of 24-hour urinary sodium excretion on the assumption that all sodium ingested was in the form of sodium chloride.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Spanish cured-pork ham | Active comparator | Other: Spanish cured-pork hamOne group will receive dry-cured pork ham of >10 months proteolysis (intervention product). Intervention: Dietary intake Dry-cured pork ham contains high doses of bioactive peptides produced during more than 10 months of proteolysis. |
| Cooked pork ham | Placebo comparator | Other: Cooked pork hamThe other group will receive cooked, uncured ham (placebo product). Intervention: Dietary intake. Cooked ham does not display bioactive peptides as they are produced during proteolysis of pork ham. |
Who may qualify
- Ages
- 35 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- Caucasian men and women,
- aged 35-60 years in good general health with an average of systolic arterial pressure >130 mmHg and diastolic >80 mmHg.
Key exclusion criteria (5 listed)
- smokers,
- Diabetes mellitus,
- diagnosed and treated hypertension,
- history of cardiovascular events (stroke, myocardial infarction or peripheral vascular disease),
- receiving medications: anti-hypertensives, vasodilators, lipid lowering therapies and fish oil supplements unless willing to discontinue prior to \& during study (all other supplements will be assessed on a case by case basis).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Spanish cured-pork hamDry-cured ham with reduced salt will be used in order to decrease the sodium intake that could affect blood pressure too. Such ham contains 25% lower salt than similar products on the market (3,7g vs 4,5g/100g). Volunteers will receive 80g of cured pork ham daily for 28 consecutive days. They can eat the interventional product at any time of the day. | Other | Spanish cured-pork ham |
| Cooked pork hamVolunteers will receive 100g of cooked pork ham daily for 28 consecutive days. They can eat the product (placebo product) at any time of the day. | Other | Cooked pork ham |
Primary outcome
Change from Baseline in Systolic Blood Pressure at 28 days
Time frame: Before/after 28 days of interventional product and placebo product
24h holters (OMROM) will be used for comparing blood pressure during the study
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jul 2016.
- Related InfoLink provided by the sponsor.
Related trials for Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Pilar Zafrilla, PhD study chair
UCAM
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Spanish cured-pork ham and Cooked pork ham in people with Hypertension and Cardiovascular Diseases, run by Universidad Católica San Antonio de Murcia at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 26 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from Baseline in Systolic Blood Pressure at 28 days (time frame: Before/after 28 days of interventional product and placebo product). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jul 2016.